The prescription of dexamphetamine to patients with schizophrenia and amphetamine dependence

Journal of Psychopharmacology

Volumn 16, Issue 4, 2002, Pages 373-377

  Carnwath, Tom ^a   Garvey, Tim ^b,d   Holland, Mark ^c  

^a NATIONAL HEALTH SERVICE   (United Kingdom)

^b GREATER MANCHESTER MENTAL HEALTH NHS FOUNDATION TRUST   (United Kingdom)

^c CPN Service   (United Kingdom)

^d MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Amphetamine; Comorbidity; Schizophrenia; Substance abuse

Indexed keywords

AMPHETAMINE; DEXAMPHETAMINE; NEUROLEPTIC AGENT; CENTRAL STIMULANT AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE EXACERBATION; DRUG DEPENDENCE; HOSPITALIZATION; HUMAN; MALE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRESCRIPTION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SCHIZOPHRENIA; TREATMENT FAILURE; TREATMENT PLANNING; CASE REPORT; DRUG ABUSE; MIDDLE AGED; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AMPHETAMINE-RELATED DISORDERS; ANTIPSYCHOTIC AGENTS; CENTRAL NERVOUS SYSTEM STIMULANTS; DEXTROAMPHETAMINE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0036905984     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988110201600414     Document Type: Article

References (25)

1. Bartles S J, Teague G B, Drake R E, et al. (1993) Service utilization and costs associated with substance use disorder among severely mentally ill patients. J Nerv Mental Dis 181: 227-232
2. Bradbeer T M, Fleming P M, Charlton P, Crichton J S (1998) Survey of amphetamine prescribing in England and Wales. Drug Alcohol Rev 17: 299-304
3. Brooke D, Taylor C, Gunn J, Maden, A (1998) Substance misusers remanded to prison - A treatment opportunity. Addiction 93: 1851-1856
4. Cesarec Z, Nyman A K (1985) Differential response to amphetamine in schizophrenia Acta Psychiatr Scand 71: 5523-5538
5. Charnaud B, Griffiths V (1998) Levels of intravenous drug misuse among clients prescribed oral dexamphetamine or oral methadone: A comparison. Drug Alcohol Depend 52: 79-84
6. Connell P H (1958) Amphetamine Psychosis. Maudsley Monograph No. 5. Oxford University Press, London
7. Dixon L, Haas G, Weiden P, Sweeney J, Frances A (1990). Acute effects of drug abuse in schizophrenic patients: Clinical observations and patients' self reports. Schizophr Bull 16: 69-79
8. Goldberg T E, Bigelow L B, Weinberger D R, Daniel D G, Kleinman J E (1991) Cognitive and behavioral effects of the coadministration of dextroamphetamine and haloperidol in schizophrenia Am J Psychiatry 148: 178-184
9. Kelly J, Heckman T, Helfrich S, Mence R, et al. (1995). Risk factors and behaviours among men in a Milwaukee homeless shelter. Am J Public Health 85: 1585
10. Klee H (1992) A new target for behavioral research - Amphetamine misuse. Br J Addict 87: 439-446
11. Klee H, Wright S, Rothwell J, Reid P, Morris J, Carnwath T, Merrill, J (1997) Amphetamine Use and Treatment: A Study of Individual and Policy Impediments to Effective Service Delivery. Report to the Department of Health Task Force to Review Services for Drug Users. Centre for Social Research and Substance Abuse, Manchester Metropolitan University, Manchester
12. Mattick R, Darke S (1995) Drug replacement treatments: Is amphetamine substitution a horse of a different colour? Drug Alcohol Rev 14: 389-394
13. McBride A J, Sullivan G, Blewett A E, Morgan S (1997) Amphetamine prescribing as a harm reduction measure: A preliminary study. Addiction Res 5: 95-112
14. Menezes PR, Johnson, S., Thornicroft G, et al. (1996) Drug and alcohol problems among individuals with severe mental illnesses in South London. Br J Psychiatry 168: 612-619
15. Pates R, Coombes N, Ford N (1996) A pilot programme in prescribing dexamphetamine for amphetamine users J Subst Misuse 1: 80-84
16. Pickering H, Stimson G (1994) Prevalence and demographic function of stimulant use. Addiction 89: 1385-1390
17. Sainsbury Centre for Mental Health (1998) Keys to Engagement: Review of Care for People with Severe Mental Illness Who Are Hard to Engage with Services. The Sainsbury Centre for Mental Health, London
18. Sanfilipo M, Wolkin A, Angrist B, van Kammen D P, Duncan E, Wieland S, Cooper T B, Peselow E D, Rotrosen J (1996) Amphetamine and negative symptoms of schizophrenia Psychopharmacology 123: 211-214
19. Seivewright N, McMahon, C. (1996). Misuse of amphetamines and related drugs. Adv Psychiatr Treatment 2: 211-218
20. Snyder S H, Bannerjee S P, Yamamura H I, Greenberg D (1974) Drugs, neurotransmitters, and schizophrenia. Science 184: 1243-1253
21. Strang J, Sheridan J (1997) Prescribing amphetamines to drug misusers: Data from the 1995 national survey of community pharmacies. Addiction 92, 833-838
22. Task Force to Review Services for Drug Misusers. 1996 Report of An Independent Review of Drug Treatment Services in England. Department of Health, London
23. Topp L, Darke S (1997) The applicability of the dependence syndrome to amphetamine. Drug Alcohol Depend 48: 113-118
24. White R (2000) Dexamphetamine substitution in the treatment of amphetamine abuse: An initial investigation. Addiction 95: 229-238
25. Yui K, Goto K, Ikemoto S, Ishiguro T, Angrist B, Duncan G E, Sheitman B, Lieberman J A, Bracha S H, Ali S F (1999) Neurobiological basis of relapse prediction in stimulant-induced psychosis and schizophrenia Mol Psychiatry 4: 512-523